Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Onconova Therapeutics Announces Exclusive License Agreement with Knight Therapeutics
Friday, November 22, 2019Onconova Therapeutics Inc a Phase stage biopharmaceutical company discovering and developing novel products to treat cancer with a focus on myelodysplastic syndromes MDS today announced they have entered into a Distribution License and Supply Agreeme...
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Thursday, November 21, 2019Astellas Pharma Inc and Welldoc Inc today announced that the companies have entered into a collaboration and license agreement directed toward the development and commercialization of digital health solutions Under the agreement Astellas and Welldoc...
Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology
Thursday, November 21, 2019Dragonfly Therapeutics Dragonfly a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease and AbbVie NYSE ABBV a researchbased global biopharmaceutical company today announced a multitarget resea...
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
Wednesday, November 20, 2019Antares Pharma Inctoday announced that it has entered into a global agreement with Idorsia Pharmaceuticals Ltd Idorsia SIX IDIA to develop a novel drugdevice product combining selatogrel Idorsias potent fastacting and highly selective PY receptor ant...
Personalis, Inc. Announces Collaboration With Merck KGaA, Darmstadt, Germany, to Identify and Develop Novel Biomarkers for Cancer Therapies
Wednesday, November 20, 2019Personalis Inc a leader in advanced genomics for cancer today announced a collaboration with Merck KGaA Darmstadt Germany a leading science and technology company to investigate novel biomarkers of response and mechanisms of resistance to cancer ther...
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
Tuesday, November 19, 2019Dicerna Pharmaceuticals Inc and Novo Nordisk AS today announced an agreement to discover and develop novel therapies for the treatment of liverrelated cardiometabolic diseases using Dicernas proprietary GalXC RNAi platform technology The collaboratio...
Alkermes to Acquire Rodin Therapeutics
Tuesday, November 19, 2019Alkermes plc and Rodin Therapeutics Inc Rodin today announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin a privately held biopharmaceutical company focused on developing novel small molecule therapeutic...
WuXi AppTec's Lab Testing Division Expands Toxicology Facility in Suzhou, China
Monday, November 18, 2019WuXi AppTec a leading global provider of RD and manufacturing services enabling companies in the pharmaceutical biotechnology and medical device industries today announced its Lab Testing Division LTD has expanded the Suzhou safety assessment facilit...
BIOCORP Signs Exclusive Deal With VITROBIO PHARMA to Produce the First Drug Treatment Against Allergy Related to Pollution
Saturday, November 16, 2019BIOCORP a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems announces today the signature of an exclusive contract with VITROBIO PHARMA a pharmaceutical research and development compan...
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
Friday, November 15, 2019Exicure Inc a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid SNA technology today announced that Allergans whollyowned subsidiary Allergan Pharmaceuticals International Limited and Exicure Inc have entered int...
